Overall, our data suggest that EZH2 inhibition reduces the association of H3K27me3 at the promoter regions of Cox2 and Hmox1 resulting in the upregulation of gene expression in IPF lung fibroblasts. Here, EZH2 is linked to idiopathic pulmonary fibrosis.